ActualEyes, Inc.
PrivateLast Round
Series C
Nov 29, 2024
Est. Valuation
$10.47M
Total Funding Raised
$6.81M
Company Overview
ActualEyes, Inc. is a biotechnology company that develops innovative cell therapy and pharmaceutical treatments for corneal endothelial disorders.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Drug Discovery
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
ActualEyes, Inc. Comparables
Compare ActualEyes, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Cellusion Inc. | 87% | |
| SYSTANE | 87% | |
| Trefoil Therapeutics | 85% | |
ActualEyes, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Nov 29, 2024 | ||||
| Series B | Jun 30, 2022 | ||||
| Seed | Oct 9, 2019 |
ActualEyes, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| WHIZ Partners, Inc. | Seed |
| Mitsubishi UFJ Capital | Seed |
| Japan Science and Technology Agency | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 29, 2024
$331K round with D. Western Therapeutics Institute and Senju Pharmaceutical.
- Jun 30, 2022
$2.4M round led by D. Western Therapeutics Institute, Inc.
ActualEyes, Inc. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about ActualEyes, Inc.'s valuation, stock price, and market status.